Delivery Order SPE2DB20D9214-SPE2DB24FD4VC

Award Date 7/12/24
Potential Completion Date 8/2/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,564,134,203 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This order was placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, valued at up to $4,999,999 through 2025. The DLA utilizes this vehicle to issue delivery...
The Defense Logistics Agency (DLA) awarded a $10,720.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,566,777,703 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products and medical supplies for the Department of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $12,864.42 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,257,903 units of the contraceptive implant NEXPLANON 68 MG by May 1, 2024. This delivery order is part of a larger five-year indefinite delivery, indefinite quantity (IDIQ) contract, SPE2DB24D9238|SPE2DB24FDQDS, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $35,734.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,068,971 Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDV enables...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of 4,564,449,404 NEXPLANON 68 MG IMPLANTS. This order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $25,167.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,557,562,613 units of the NEXPLANON 68 MG implants, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue firm fixed-price orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,565,711,445 units of NEXPLANON 68 MG IMPLANTS. The delivery order, valued at $35,734.50, was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. DMS Pharmaceutical Group is a key supplier in the federal...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of NEXPLANON 68 MG IMPLANTS. The contract has a ceiling value of $2,082.93 and an ultimate completion date of February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which enables the DLA to issue...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 68 mg NEXPLANON contraceptive implants. The contract, valued at $35,734.50, has an ultimate completion date of April 8, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract SPE2DB24FZR56 with the Defense Logistics Agency, which is valued at up to $4,999,999 through the end of...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4VC
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This contract does not have a set-aside designation.

Generated 10/11/24, 9:11 AM